Gene | Score gda | Association Type | Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
0.080 | Biomarker | disease | BEFREE | This study provided evidence that suppression of CTGF could be a viable strategy for hypertrophic scar reduction therapy and that further study of the antisense oligonucleotide EXC 001 was indicated. | 30045185 | 2018 | ||||
|
0.080 | AlteredExpression | disease | BEFREE | We hypothesised that a feedback mechanism of the transforming growth factor (TGF)-β1 signalling pathway, triggered by high-level TGF-β1, activates platelet-rich plasma (PRP) release to reduce connective tissue growth factor (CTGF) production and expression of CTGF mRNA in hypertrophic scar dermal fibroblasts. | 29781178 | 2018 | ||||
|
0.080 | AlteredExpression | disease | BEFREE | MiR-6836-3p promoted the development of HS by increasing the expression of CTGF. | 30024593 | 2018 | ||||
|
0.080 | AlteredExpression | disease | BEFREE | The expression of connective tissue growth factor (CTGF/CCN2) was upregulated both in HS tissues and HSFs, which is proposed to play a key role in ECM deposition in HS. | 27075467 | 2016 | ||||
|
0.080 | Biomarker | disease | BEFREE | In this study, we investigated the role of integrin α(ν)β(3) in the differentiation of hypertrophic scar fibroblasts (HTSFs) induced by CCN2. | 25174803 | 2014 | ||||
|
0.080 | Biomarker | disease | BEFREE | CCN2 plays an important role in the pathogenesis of hypertrophic scars (HTSs). | 23494140 | 2013 | ||||
|
0.080 | AlteredExpression | disease | BEFREE | Neuregulin induces CTGF expression in hypertrophic scarring fibroblasts. | 22350758 | 2012 | ||||
|
0.080 | Biomarker | disease | BEFREE | Activation of peroxisome proliferator-activated receptor-gamma inhibits transforming growth factor-beta1 induction of connective tissue growth factor and extracellular matrix in hypertrophic scar fibroblasts in vitro. | 19466435 | 2009 |